ISPD Position Statement on Reducing the Risks of Peritoneal Dialysis–Related Infections

Kavanagh D. , Prescott G.J. , Mactier R.A. Peritoneal dialysis–associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant 2004; 19: 2584–91.

Hoshii S. , Wada N. , Honda M. on behalf of the Japanese Study Group of Pediatric Peritoneal Dialysis. A survey of peritonitis and exit-site and/or tunnel infections in Japanese children on PD. Pediatr Nephrol 2006; 21: 828–34.

Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 2006; (103): S55–62.

Nakamoto H. , Kawaguchi Y. , Suzuki H. Is technique survival on peritoneal dialysis better in Japan? Perit Dial Int 2006; 26: 136–43.

Rodrigues A.S. , Matos C.B. , Silva F. , Fonseca I. , Nogueira C. , Santos J. Long-term peritoneal dialysis experience in Portugal. Int J Artif Organs 2006; 29: 1109–16.

Fang W. , Qian J. , Lin A. , Rowaie F. , Ni Z. , Yao Q. Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre. Nephrol Dial Transplant 2008; 23: 4021–8.

Chen T.W. , Li S.Y. , Chen J.Y. , Yang W.C. Training of peritoneal dialysis patients—Taiwan's experiences. Perit Dial Int 2008; 28(Suppl 3): S72–5.

Akman S. , Bakkaloglu S.A. , Ekim M. , Sever L. , Noyan A. , Aksu N. Peritonitis rates and common microorganisms in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. Pediatr Int 2009; 51: 246–9.

Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003. Perit Dial Int 2009; 29: 297–302.

Kopriva–Altfahrt G. , König P. , Mündle M. , Prischl F. , Roob J.M. , Wiesholzer M. Exit-site care in Austrian peritoneal dialysis centers—a nationwide survey. Perit Dial Int 2009; 29: 330–9.

Moraes T.P. , Pecoits–Filho R. , Ribeiro S.C. , Rigo M. , Silva M.M. , Teixeira P.S. Peritoneal dialysis in Brazil: twenty-five years of experience in a single center. Perit Dial Int 2009; 29: 492–8.

Nessim S.J. , Bargman J.M. , Austin P.C. , Nisenbaum R. , Jassal S.V. Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol 2009; 4: 1195–200.

Fontán M.P. , Cambre H.D. , Rodríguez–Carmona A. , Muñiz A.L. , Falcón T.G. Treatment of peritoneal dialysis–related peritonitis with ciprofloxacin monotherapy: clinical outcomes and bacterial susceptibility over two decades. Perit Dial Int 2009; 29: 310–18.

Qamar M. , Sheth H. , Bender F.H. , Piraino B. Clinical outcomes in peritoneal dialysis: impact of continuous quality improvement initiatives. Adv Perit Dial 2009; 25: 76–9.

Rüger W. , van Ittersum F.J. , Comazzetto L.F. , Hoeks S.E. , Ter Wee P.M. Similar peritonitis outcome in CAPD and APD patients with dialysis modality continuation during peritonitis. Perit Dial Int 2011; 31: 39–47.

Castrale C. , Evans D. , Verger C. , Fabre E. , Aguilera D. , Ryckelynck J.P. Peritoneal dialysis in elderly patients: report from the French Peritoneal Dialysis Registry (RDPLF). Nephrol Dial Transplant 2010; 25: 255–62.

Cleper R. , Davidovits M. , Kovalski Y. , Samsonov D. , Amir J. , Krause I. Peritonitis in a pediatric dialysis unit: local profile and implications. Isr Med Assoc J 2010; 12: 348–52.

Fahim M. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Nephrol Dial Transplant 2010; 25: 3386–92.

Jarvis E.M. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Predictors, treatment, and outcomes of non-Pseudomonas gram-negative peritonitis. Kidney Int 2010; 78: 408–14.

Shigidi M.M. , Fituri O.M. , Chandy S.K. , Asim M. , Al Malki H.A. , Rashed A.H. Microbial spectrum and outcome of peritoneal dialysis related peritonitis in Qatar. Saudi J Kidney Dis Transpl 2010; 21: 168–73.

Li P.K. , Szeto C.C. , Piraino B. , Bernardini J. , Figueiredo A.E. , Gupta A. Peritoneal dialysis–related infections recommendations: 2010 update. Perit Dial Int 2010; 30: 393–423.

Figueiredo A. , Goh B.L. , Jenkins S. , Johnson D.W. , Mactier R. , Ramalakshmi S. Clinical practice guidelines for peritoneal access. Perit Dial Int 2010; 30: 424–9.

Borg D. , Shetty A. , Williams D. , Faber M.D. Fivefold reduction in peritonitis using a multifaceted continuous quality initiative program. Adv Perit Dial 2003; 19: 202–5.

Schaefer F. , Kandert M. , Feneberg R. Methodological issues in assessing the incidence of peritoneal dialysis-associated peritonitis in children. Perit Dial Int 2002; 22: 234–8.

Finkelstein F.O. Structural requirements for a successful chronic peritoneal dialysis program. Kidney Int Suppl 2006; (103): S118–21.

Nasso L. Our peritonitis continuous quality improvement project: where there is a will there is a way. CANNT J 2006; 16: 20–3.

Piraino B. , Bernardini J. , Sorkin M. A five-year study of the microbiologic results of exit site infections and peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1987; 10: 281–6.

Strippoli G.F. , Tong A. , Johnson D. , Schena F.P. , Craig J.C. Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev 2004; (4): CD004680.

Eklund B.H. , Honkanen E.O. , Kala A.R. , Kyllönen L.E. Peritoneal dialysis access: prospective randomized comparison of the swan neck and Tenckhoff catheters. Perit Dial Int 1995; 15: 353–6.

Lo W.K. , Lui S.L. , Li F.K. , Choy B.Y. , Lam M.F. , Tse K.C. A prospective randomized study on three different peritoneal dialysis catheters. Perit Dial Int 2003; 23(Suppl 2): S127–31.

Gadallah M.F. , Ramdeen G. , Mignone J. , Patel D. , Mitchell L. , Tatro S. Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters. Am J Kidney Dis 2000; 36: 1014–9.

Lindblad A.S. , Hamilton R.W. , Nolph K.D. , Novak J.W. A retrospective analysis of catheter configuration and cuff type: a National CAPD Registry report. Perit Dial Int 1988; 8: 129–33.

Eklund B.H. , Honkanen E.O. , Kala A.R. , Kyllönen L.E. Peritoneal dialysis access: prospective randomized comparison of the swan neck and Tenckhoff catheters. Perit Dial Int 1995; 15: 353–6.

Golper T.A. , Brier M.E. , Bunke M. , Schreiber M.J. , Bartlett D.K. , Hamilton R.W. Risk factors for peritonitis in long-term peritoneal dialysis: the Network 9 peritonitis and catheter survival studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies. Am J Kidney Dis 1996; 28: 428–36.

Strippoli G.F. , Tong A. , Johnson D. , Schena F.P. , Craig J.C. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis 2004; 44: 591–603.

Bender F.H. , Bernardini J. , Piraino B. Prevention of infectious complications in peritoneal dialysis: best demonstrated practices. Kidney Int Suppl 2006; (103): S44–54.

Hall G. , Bogan A. , Dreis S. , Duffy A. , Greene S. , Kelley K. New directions in peritoneal dialysis patient training. Nephrol Nurs J 2004; 31: 149–54,159–63.

Bernardini J. Price V, Figueiredo A. ISPD guidelines/ recommendations: peritoneal dialysis patient training, 2006. Perit Dial Int 2006; 26: 625–32.

Holloway M. , Mujais S. , Kandert M. , Warady B.A. Pediatric peritoneal dialysis training: characteristics and impact on peritonitis rates. Perit Dial Int 2001; 21: 401–4.

Chow K.M. , Szeto C.C. , Law M.C. , Fun Fung J.S. , Li K.T.P. Influence of peritoneal dialysis training nurses’ experience on peritonitis rates. Clin J Am Soc Nephrol 2007; 2: 647–52.

Russo R. , Manili L. , Tiraboschi G. , Amar K. , De Luca M. , Alberghini E. Patient re-training in peritoneal dialysis: why and when it is needed. Kidney Int Suppl 2006; (103): S127–32.

Ballerini L. , Paris V. Nosogogy: when the learner is a patient with chronic kidney failure. Kidney Int Suppl 2006; (103): S122–6.

Martin A. , Simmons W.K. 6. Structural basis of semantic memory. In: Byrne J.H. , ed. Concise Learning and Memory: The Editor's Selection. San Diego, CA: Elsevier/Academic; 2009.

Arndt J. The role of memory activation in creating false memories of encoding context. J Exp Psychol Learn Mem Cogn 2010; 36: 66–79.

Bordin G. , Casati M. , Sicolo N. , Zuccherato N. , Eduati V. Patient education in peritoneal dialysis: an observational study in Italy. J Ren Care 2007; 33: 165–71.

Dong J. , Chen Y. Impact of the bag exchange procedure on risk of peritonitis. Perit Dial Int 2010; 30: 440–7.

Bernardini J. , Price V. , Figueiredo A. , Riemann A. , Leung D. International survey of peritoneal dialysis training programs. Perit Dial Int 2006; 26: 658–63.

Piraino B. , Bernardini J. , Bender F.H. An analysis of methods to prevent peritoneal dialysis catheter infections. Perit Dial Int 2008; 28: 437–43.

Figueiredo A.E. , Poli de Figueiredo C.E. , d'Avila D.O. Peritonitis in CAPD: to mask or not? Perit Dial Int 2000; 20: 354–8.

Figueiredo A.E. , Poli de Figueiredo C.E. , d'Avila D.O. Bag exchange in continuous ambulatory peritoneal dialysis without use of a face mask: experience of five years. Adv Perit Dial 2001; 17: 98–100.

Li P.K. , Law M.C. , Chow K.M. , Chan W.K. , Szeto C.C. , Cheng Y.L. Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis: a prospective, randomized, controlled, multicenter study. Am J Kidney Dis 2002; 40: 373–80.

Monteón F. , Correa–Rotter R. , Paniagua R. , Amato D. , Hurtado M.E. , Medina J.L. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. The Mexican Nephrology Collaborative Study Group. Kidney Int 1998; 54: 2123–8.

Cox S.D. , Steddon S. , Mallinder S. , Fan S.L. , Punzalan S. Re-training and switching of PD system to reduce recurrent gram-positive PD peritonitis. J Ren Care 2006; 32: 198–201.

Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems Canadian CAPD Clinical Trials Group. Perit Dial Int 1989; 9: 159–63.

Harris D.C. , Yuill E.J. , Byth K. , Chapman J.R. , Hunt C. Twin-versus single-bag disconnect systems: infection rates and cost of continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996; 7: 2392–8.

Kiernan L. , Kliger A. , Gorban–Brennan N. , Juergensen P. , Tesin D. , Vonesh E. Comparison of continuous ambulatory peritoneal dialysis-related infections with different “Y-tubing” exchange systems. J Am Soc Nephrol 1995; 5: 1835–8.

Li P.K. , Szeto C.C. , Law M.C. , Chau K.F. , Fung K.S. , Leung C.B. Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: a randomized prospective multicenter study. Am J Kidney Dis 1999; 33: 535–40.

Strippoli G.F. , Tong A. , Johnson D. , Schena F.P. , Craig J.C. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. J Am Soc Nephrol 2004; 15: 2735–46.

Piraino B. , Sheth H. Peritonitis—does peritoneal dialysis modality make a difference? Blood Purif 2010; 29: 145–9.

Mehrotra R. , Chiu Y.W. , Kalantar–Zadeh K. , Vonesh E. The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int 2009; 76: 97–107.

Rabindranath K.S. , Adams J. , Ali T.Z. , MacLeod A.M. , Vale L. , Cody J. Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease. Cochrane Database Syst Rev 2007; (2): CD006515.

Rodríguez–Carmona A. , Pérez Fontán M. , García Falcón T. , Fernández Rivera C. , Valdés F. A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis. Perit Dial Int 1999; 19: 253–8.

Chow J. , Munro C. , Wong M. , Gonzalez N. , Ku M. , Neville S. HomeChoice automated peritoneal dialysis machines: the impact of reuse of tubing and cassettes. Perit Dial Int 2000; 20: 336–8.

Ponferrada L.P. , Prowant B.F. , Rackers J.A. , Pickett B. , Satalowich R. , Khanna R. A cluster of gram-negative peritonitis episodes associated with reuse of HomeChoice cycler cassettes and drain lines. Perit Dial Int 1996; 16: 636–8.

Ramalakshmi S. , Bernardini J. , Piraino B. Nightly intermittent peritoneal dialysis to initiate peritoneal dialysis. Adv Perit Dial 2003; 19: 111–14.

Tacconelli E. , Carmeli Y. , Aizer A. , Ferreira G. , Foreman M.G. , D'Agata E.M. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003; 37: 1629–38.

Strippoli G.F. , Tong A. , Johnson D. , Schena F.P. , Craig J.C. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis 2004; 44: 591–603.

Amato D. , de Jesús Ventura M. , Miranda G. , Leaños B. , Alcántara G. , Hurtado M.E. Staphylococcal peritonitis in continuous ambulatory peritoneal dialysis: colonization with identical strains at exit site, nose, and hands. Am J Kidney Dis 2001; 37: 43–8.

Lye W.C. , Leong S.O. , van der Straaten J. , Lee E.J. Staphylococcus aureus CAPD-related infections are associated with nasal carriage. Adv Perit Dial 1994; 10: 163–5.

Bernardini J. , Piraino B. , Holley J. , Johnston J.R. , Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin Am J Kidney Dis 1996; 27: 695–700.

Bernardini J. , Bender F. , Florio T. , Sloand J. , Palmmontalbano L. , Fried L. Randomized double blinded trial of antibiotic exit site cream for the prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005; 16: 539–45.

Herwaldt L.A. , Boyken L.D. , Coffman S. , Hochstetler L. , Flanigan M.J. Sources of Staphylococcus aureus for patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2003; 23: 237–41.

Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol 1996; 7: 2403–8.

Chu K.H. , Choy W.Y. , Cheung C.C. , Fung K.S. , Tang H.L. , Lee W. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections. Perit Dial Int 2008; 28: 505–8.

Xu G. , Tu W. , Xu C. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Nephrol Dial Transplant 2010; 25: 587–92.

Piraino B. , Bernardini J. , Florio T. , Fried L. Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Perit Dial Int 2003; 23: 456–9.

Luzar M.A. , Brown C.B. , Balf D. , Hill L. , Issad B. , Monnier B. Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial. Perit Dial Int 1990; 10: 25–9.

Mahajan S. , Tiwari S.C. , Kalra V. , Bhowmik D.M. , Agarwal S.K. , Dash S.C. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population. Perit Dial Int 2005; 25: 473–7.

Sit D. , Kadiroglu A.K. , Kayabasi H. , Yilmaz M.E. Prophylactic intranasal mupirocin ointment in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients. Adv Ther 2007; 24: 387–93.

Lim C.T. , Wong K.S. , Foo M.W. The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital. Nephrol Dial Transplant 2005; 20: 1702–6.

Piraino B. Can we reduce the rates of Staphylococcus aureus and other peritonitis in peritoneal dialysis patients? Perit Dial Int 2010; 30: 277–9.

Riu S. , Ruiz C.G. , Martinez–Vea A. , Peralta C. , Oliver J.A. Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment. Nephrol Dial Transplant 1998; 13: 1870–1.

Lineaweaver W. , Howard R. , Soucy D. , McMorris S. , Freeman J. , Crain C. Topical antimicrobial toxicity. Arch Surg 1985; 120: 267–70.

Heling I. , Rotstein I. , Dinur T. , Szwec-Levine Y. , Steinberg D. Bactericidal and cytotoxic effects of sodium hypochlorite and sodium dichlorosiocyanurate solutions in vitro. J Endod 2001; 27: 278–80.

Doughty D. A rational approach to the use of topical antiseptics. J Wound ostomy Continence Nurs 1994; 21: 224–31.

Tatnall F.M. , Leigh I.M. , Gibson J.R. Comparative study of antiseptic toxicity on basal keratinocytes, transformed human keratinocytes and fibroblasts. Skin Pharmacol 1990; 3: 157–63.

Hasbargen B.J. , Rodgers D.J. , Hasbargen J.A. , Quinn M.J. , James M.K. Exit-site care—is it time for a change? Perit Dial Int 1993; 13(Suppl 2): S313–15.

United States, Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) Hand hygiene in healthcare settings (web page). Atlanta, GA: CDC; 2011. [Available online at: http://www.cdc.gov/Handhygiene; cited: 11 May 2011]

Wong S.S. , Chu K.H. , Cheuk A. , Tsang W.K. , Fung S.K. , Chan H.W. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site. Perit Dial Int 2003; 23(Suppl 2): S153–8.

Lobbedez T. , Gardam M. , Dedier H. , Burdzy D. , Chu M. , Izatt S. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol Dial Transplant 2004; 19: 3140–3.

Pérez–Fontán M. , Rosales M. , Rodríguez–Carmona A. , Falcón T.G. , Valdés F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002; 39: 337–41.

Annigeri R. , Conly J. , Vas S. , Dedier H. , Prakashan K.P. , Bargman J.M. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001; 21: 554–9.

Johnson D.W. , Clark C. , Isbel N.M. , Hawley C.M. , Beller E. , Cass A. on behalf of the Honeypot Study Group. The Honeypot Study protocol: a randomized controlled trial of exit-site application of Medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Perit Dial Int 2009; 29: 303–9.

Jassal S.V. , Lok CE on behalf of the MP3 Study Group. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study). Perit Dial Int 2008; 28: 67–72.

Singharetnam W. , Holley J.L. Acute treatment of constipation may lead to transmural migration of bacteria resulting in gram-negative, polymicrobial, or fungal peritonitis. Perit Dial Int 1996; 16: 423–5.

Wood C.J. , Fleming V. , Turnidge J. , Thomson N. , Atkins R.C. Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: report of eight cases and a review of the literature. Am J Kidney Dis 1992; 19: 257–63.

Chuang Y.W. , Shu K.H. , Yu T.M. , Cheng C.H. , Chen C.H. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant 2009; 24: 1603–8.

Szeto C.C. , Kwan B.C. , Chow K.M. , Law M.C. , Pang W.F. , Chung K.Y. Recurrent and relapsing peritonitis: causative organisms and response to treatment. Am J Kidney Dis 2009; 54: 702–10.

Shu K.H. , Chang C.S. , Chuang Y.W. , Chen C.H. , Cheng C.H. , Wu M.J. Intestinal bacterial overgrowth in CAPD patients with hypokalaemia. Nephrol Dial Transplant 2009; 24: 1289–92.

Fried L. , Bernardini J. , Piraino B. Iatrogenic peritonitis: the need for prophylaxis. Perit Dial Int 2000; 20: 343–5.

Yip T. , Tse K.C. , Lam M.F. , Cheng S.W. , Lui S.L. , Tang S. Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients. Perit Dial Int 2007; 27: 560–4.

Machuca E. , Ortiz A.M. , Rabagliati R. Streptococcus viridans–associated peritonitis after gastroscopy. Adv Perit Dial 2005; 21: 60–2.

Schweinburg F.B. , Seligman A.M. , Fine J. Transmural migration of intestinal bacteria: a study based on the use of radioactive Escherichia coli. N Engl J Med 1950; 242: 747–51.

Harwell C.M. , Newman L.N. , Cacho C.P. , Mulligan D.C. , Schulak J.A. , Friedlander M.A. Abdominal catastrophe: visceral injury as a cause of peritonitis in patients treated by peritoneal dialysis. Perit Dial Int 1997; 17: 586–94.

Lee Y.J. , Cho A.J. , Lee J.E. , Huh W. , Kim Y.G. , Oh H.Y. Evolving appendicitis presenting as culture-negative peritonitis with minimal symptoms in a patient on continuous ambulatory peritoneal dialysis. Ren Fail 2010; 32: 884–7.

Poortvliet W. , Selten H.P. , Raasveld M.H. , Klemt–Kropp M. CAPD peritonitis after colonoscopy: follow the guidelines. Neth J Med 2010; 68: 377–8.

Yip T. , Tse K.C. , Lam M.F. , Cheng S.W. , Lui S.L. , Tang S. Colonic diverticulosis as a risk factor for peritonitis in Chinese peritoneal dialysis patients. Perit Dial Int 2010; 30: 187–91.

Holley J.L. , Udekwu A. , Rault R. , Piraino B. The risks of laparoscopic cholecystectomy in CAPD compared with hemodialysis patients: a study of ten patients. Perit Dial Int 1994; 14: 395–6.

Tison A. , Lozowy C. , Benjamin A. , Usher R. , Prichard S. Successful pregnancy complicated by peritonitis in a 35-year-old CAPD patient. Perit Dial Int 1996; 16(Suppl 1): S489–91.

Li P.K. , Leung C.B. , Leung A.K. , Luk W.K. , Lai K.N. Posthysteroscopy fungal peritonitis in a patient on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1993; 21: 446–8.

Ceri M. , Altay M. , Unverdi S. , Kurultak I. , Duranay M. An unusual presentation of vaginal leakage in a peritoneal dialysis patient. Perit Dial Int 2010; 30: 663–5.

Cobelo C. , Ros S. , Trujillo C. , Garcia P. An unusual case of vaginal leak in a patient on peritoneal dialysis. Perit Dial Int 2010; 30: 665–6.

Neumann J.L. , Moran J. Peritonitis due to a peritoneal vaginal fistula. Nephrol Nurs J 2010; 37: 177–8,181.

Yildiz N. , Turhan P. , Bilgic O. , Ergüven M. , Candan C. Vaginal dialysate leakage in a child on peritoneal dialysis. Perit Dial Int 2010; 30: 666–7.

Liakopoulos V. , Petinaki E. , Bouchlariotou S. , Mertens P.R. , Trakala M. , Kourti P. Group B Streptococcus (Streptococcus agalactiae) peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 2004; 62: 391–6.

Scanziani R. , Dozio B. , Baragetti I. , Grillo P. , Colombo L. , De Liso S. Vaginal colonization with group B Streptococcus (Streptococcus agalactiae) and peritonitis in a woman on CAPD. Nephrol Dial Transplant 1999; 14: 2222–4.

de Los Santos C.A. , Prado Lima Figueiredo A.E. , Poli-de-Figueiredo C.E. Streptococcus agalactiae: a rare peritoneal infection in a continuous ambulatory peritoneal dialysis patient. Ren Fail 2010; 32: 1123–4.

Matuszkiewicz–Rowinska J. Update on fungal peritonitis and its treatment. Perit Dial Int 2009; 29(Suppl 2): S161–5.

Prabhu M.V. , Subhramanyam S.V. , Gandhe S. , Antony S.K. , Nayak K.S. Prophylaxis against fungal peritonitis in CAPD— a single center experience with low-dose fluconazole. Ren Fail 2010; 32: 802–5.

Prasad K.N. , Prasad N. , Gupta A. , Sharma R.K. , Verma A.K. , Ayyagari A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect 2004; 48: 96–101.

Wang A.Y. , Yu A.W. , Li P.K. , Lam P.K. , Leung C.B. , Lai K.N. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis 2000; 36: 1183–92.

Goldie S.J. , Kiernan–Troidle L. , Torres C. , Gorban–Brennan N. , Dunne D. , Kliger A.S. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996; 28: 86–91.

Miles R. , Hawley C.M. , McDonald S.P. , Brown F.G. , Rosman J.B. , Wiggins K.J. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 2009; 76: 622–8.

Záruba K. , Peters J. , Jungbluth H. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years’ experience. Am J Kidney Dis 1991; 17: 43–6. [Erratum in: Am J Kidney Dis 1991; 17:726]

Robitaille P. , Mérouani A. , Clermónt M.J. , Hébert E. Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Perit Dial Int 1995; 15: 77–9.

Thodis E. , Vas S.I. , Bargman J.M. , Singhal M. , Chu M. , Oreopoulos D.G. Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1998; 18: 583–9.

Wadhwa N.K. , Suh H. , Cabralda T. Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients. Adv Perit Dial 1996; 12: 189–91.

Williams P.F. , Moncrieff N. , Marriott J. No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit Dial Int 2000; 20: 352–3.

Lo W.K. , Chan C.Y. , Cheng S.W. , Poon J.F. , Chan D.T. , Cheng I.K. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996; 28: 549–52.

Wong P.N. , Lo K.Y. , Tong G.M. , Chan S.F. , Lo M.W. , Mak S.K. Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit Dial Int 2007; 27: 531–6.

Restrepo C. , Chacon J. , Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Perit Dial Int 2010; 30: 619–25.

Williams A.J. , Boletis I. , Johnson B.F. , Raftery A.T. , Cohen G.L. , Moorhead P.J. Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis. Perit Dial Int 1989; 9: 65–7.

Finkelstein E.S. , Jekel J. , Troidle L. , Gorban–Brennan N. , Finkelstein F.O. , Bia F.J. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis 2002; 39: 1278–86.

Mulhern J.G. , Braden G.L. , O'Shea M.H. , Madden R.L. , Lipkowitz G.S. , Germain M.J. Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients. Am J Kidney Dis 1995; 25: 611–15.

Swartz R. , Messana J. , Reynolds J. , Ranjit U. Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections. Kidney Int 1991; 40: 1160–5.

Duranay M. , Kanbay M. , Turgut F. , Altay M. , Akcay A. Comparison of incidence of peritonitis between peritoneal dialysis solution types. Nephron Clin Pract 2007; 106: c57–60.

Montenegro J. , Saracho R. , Gallardo I. , Martínez I. , Muñoz R. , Quintanilla N. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis. Nephrol Dial Transplant 2007; 22: 1703–8.

Ahmad S. , Sehmi J.S. , Ahmad–Zakhi K.H. , Clemenger M. , Levy J.B. , Brown E.A. Impact of new dialysis solutions on peritonitis rates. Kidney Int Suppl 2006; (103): S63–6.

Furkert J. , Zeier M. , Schwenger V. Effects of peritoneal dialysis solutions low in GDPs on peritonitis and exit-site infection rates. Perit Dial Int 2008; 28: 637–40.

Williams J.D. , Topley N. , Craig K.J. , Mackenzie R.K. , Pischetsrieder M. , Lage C on behalf of the Euro-Balance Trial Group. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (Balance) on the peritoneal membrane. Kidney Int 2004; 66: 408–18.

Fan S.L. , Pile T. , Punzalan S. , Raftery M.J. , Yaqoob M.M. Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function. Kidney Int 2008; 73: 200–6.

Prasad N. , Gupta A. , Sharma R.K. , Sinha A. , Kumar R. Impact of nutritional status on peritonitis in CAPD patients. Perit Dial Int 2007; 27: 42–7.

Wang Q. , Bernardini J. , Piraino B. , Fried L. Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis 2003; 41: 664–9.

Dabbagh S. , Fassinger N. , Clement K. , Fleischmann L.E. The effect of aggressive nutrition on infection rates in patients maintained on peritoneal dialysis. Adv Perit Dial 1991; 7: 161–4.

Troidle L. , Watnick S. , Wuerth D.B. , Gorban–Brennan N. , Kliger A.S. , Finkelstein F.O. Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis 2003; 42: 350–4.

Rudnicki M. , Kerschbaum J. , Hausdorfer J. , Mayer G. , König P. Risk factors for peritoneal dialysis-associated peritonitis: the role of oral active vitamin D. Perit Dial Int 2010; 30: 541–8.

Satomura A. , Yanai M. , Fujita T. , Arashima Y. , Kumasaka K. , Nakane C. Peritonitis associated with Pasteurella multocida: molecular evidence of zoonotic etiology. Ther Apher Dial 2010; 14: 373–6.

Schiller B. , Alcaraz M. , Hadley K. , Moran J. Peritonitis and zoonosis: your best friend sometimes isn't! Perit Dial Int 2011; 31: 127–30.

Odudu A. , Wilkie M. Controversies in the management of infective complications of peritoneal dialysis. Nephron Clin Pract 2011; 118: c301–8.

Jiang Z. , Yu X. Advancing the use and quality of peritoneal dialysis by developing a peritoneal dialysis satellite center program. Perit Dial Int 2011; 31: 121–6.

Borg D. , Shetty A. , Williams D. , Faber M.D. Fivefold reduction in peritonitis using a multifaceted continuous quality initiative program. Adv Perit Dial 2003; 19: 202–5.